Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Other Non-Current Liabilities (2020 - 2025)

SOPHiA GENETICS's Other Non-Current Liabilities history spans 6 years, with the latest figure at $876000.0 for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 159.94% to $876000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $876000.0, a 159.94% increase, with the full-year FY2025 number at $876000.0, up 159.94% from a year prior.
  • Other Non-Current Liabilities hit $876000.0 in Q4 2025 for SOPHiA GENETICS, up from $671000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for SOPH hit a ceiling of $876000.0 in Q4 2025 and a floor of $124000.0 in Q1 2024.
  • Historically, Other Non-Current Liabilities has averaged $409578.9 across 5 years, with a median of $420000.0 in 2024.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 75.36% in 2023 and later skyrocketed 171.77% in 2025.
  • Tracing SOPH's Other Non-Current Liabilities over 5 years: stood at $471000.0 in 2021, then crashed by 63.91% to $170000.0 in 2022, then surged by 96.47% to $334000.0 in 2023, then increased by 0.9% to $337000.0 in 2024, then skyrocketed by 159.94% to $876000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for SOPH at $876000.0 in Q4 2025, $671000.0 in Q3 2025, and $626000.0 in Q2 2025.